Source Photonics Reaches Significant Milestone to Surpass 2 million 28G EML Chips Shipped
Further demonstrates industry leadership position in delivering EML laser chips with superior quality and incident…
News
OWC Returns to NAMM 2022 with New Storage and Connectivity Products for Audio Pros
Technology leader showcases new innovative solutions for the pro audio industry WOODSTOCK, Ill.–(BUSINESS WIRE)–OWC®, a…
Tiller Launches New Personal Finance Service for Excel, Partners on Exclusive Offer for Microsoft 365 Subscribers
Tiller’s personal finance service now offers a full suite of tools for customers to manage…
Shark Tank’s Daymond John to Open Automate 2022 in Detroit Next Monday
John to share unique goal-setting and achievement strategies, followed by keynotes from General Motors, Boston…
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of LMP Automotive Holdings, Inc. (LMPX) Investors
LOS ANGELES–(BUSINESS WIRE)–$STOCKS—The Law Offices of Frank R. Cruz announces that a class action lawsuit…
Leading Supercomputer Sites Choose Cerebras for AI Acceleration
Across the United States and Europe, supercomputing centers depend on wafer-scale solutions from Cerebras for…
OneStream Software Receives Top Marks and a 100% Recommendation Score in BARC Survey Covering Planning and Financial Performance Management Products
Earns 15 top rankings and 33 leading positions in four peer groups in The Planning…
EQUITY ALERT: Rosen Law Firm Encourages LMP Automotive Holdings, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – LMPX
NEW YORK–(BUSINESS WIRE)–WHY: Rosen Law Firm, a global investor rights law firm, announces the filing…
Qumulo Named TOP 5 Rising Storage Vendor for Life Sciences by Leading Technology Research Firm DCIG
Qumulo enables extreme scalability and performance for life sciences organizations managing data-intensive innovations SEATTLE–(BUSINESS WIRE)–Qumulo,…
Leading Independent Proxy Advisory Firm ISS Recommends Spirit Shareholders ‘Vote No’ on Frontier Transaction
ISS notes the JetBlue offer is superior from a financial standpoint and that JetBlue offer…
Biora Therapeutics Shares Presentation of Patient Data Establishing Correlation Between Drug Levels in Colon and Patient Outcomes in Ulcerative Colitis
Oral Presentation Delivered at DDW 2022 Informs Clinical Study Design for Biora’s Targeted Therapeutics Platform…
Y-mAbs Announces FDA Acceptance of Biologics License Application for OMBLASTYS® (omburtamab) for the Treatment of Neuroblastoma for Priority Review
NEW YORK, May 31, 2022 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
BioCorRx to Present at the LD Micro Invitational XII on June 7th
ANAHEIM, CA, May 31, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”),…
Clover Doses First Participants in Phase 1 Trial with SCB-2020S, a Potentially Broadly Protective Chimeric COVID-19 Vaccine Candidate
–Phase 1 clinical trial will evaluate safety and immunogenicity of several formulations of SCB-2020S as…
Virax Biolabs Announces the Formation of Advisory Board of Industry Leaders
London, United Kingdom, May 31, 2022 (GLOBE NEWSWIRE) — Virax Biolabs Group Limited (“Virax” or…
Veru to Present Three Presentations at the 2022 American Society for Clinical Oncology Annual Meeting on June 3-7
MIAMI, May 31, 2022 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a biopharmaceutical company focused…
Galecto to Participate at Jefferies Healthcare Conference
BOSTON, May 31, 2022 (GLOBE NEWSWIRE) — Galecto, Inc. (NASDAQ: GLTO), a clinical stage biotechnology…
Agenus Advances Portfolio with 6 Clinical Collaborations
LEXINGTON, Mass., May 31, 2022 (GLOBE NEWSWIRE) — Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company…
Fortress Biotech Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating Dotinurad for the Treatment of Gout in the United States
Dotinurad is a potential best-in-class urate transporter (URAT1) inhibitor in clinical development at Fortress’ subsidiary…
SciSparc to Collaborate with Polyrizon for Brain Targeting Using Intranasal Hydrogel Systems
SciSparc will use its SCI-160 technology platform for treating pain in combination with Polyrizons‘ Trap…